MDMB-CHMINACA

AB-CHMINACA (Cay-15434) is an indazole-based synthetic cannabinoid (CB) that is structurally related to AB-FUBINACA (Cay-14039), a high affinity ligand of the central CB1 receptor (Ki = 0.9 nM), by having a cyclohexyl group substituted for the 4-fluorophenyl group. MDMB-CHMINACA is structurally related to AB-CHMINACA by bearing a similar cyclohexyl group, however, the terminal aminocarbonyl moiety is replaced by a methyl ester group and the isobutyl moiety is substituted with a tert-butyl group. The physiological and toxicological properties of this compound have not been determined. This product is intended for research and forensic applications.Formal Name: N-[[1-(cyclohexylmethyl)-1H-indazol-3-yl]carbonyl]-3-methyl-L-valine, methyl ester. CAS Number: 1185888-32-7. Molecular Formula: C22H31N3O3. Formula Weight: 385.5. Purity: >98%. Formulation: (Request formulation change), A solution in acetonitrile. Solubility: DMF: 20 mg/ml, DMSO: 5 mg/ml, Ethanol: 20 mg/ml. lambdamax: 210, 302 nm. SMILES: O=C(N[C@H](C(OC)=O)C(C)(C)C)C1=NN(CC2CCCCC2)C3=C1C=CC=C3. InChi Code: InChI=1S/C22H31N3O3/c1-22(2,3)19(21(27)28-4)23-20(26)18-16-12-8-9-13-17(16)25(24-18)14-15-10-6-5-7-11-15/h8-9,12-13,15,19H,5-7,10-11,14H2,1-4H3,(H,23,26)/t19-/m1/s1. InChi Key: DGQMLBSSRFFINY-LJQANCHMSA-N.